相关实验视频
Updated: Jun 15, 2025

11:36
Glycan Node Analysis: A Bottom-up Approach to Glycomics
Published on: May 22, 2016
10.3K
在瘤发生中的O-GlcNAcylation及其对癌症治疗的影响
Dize Zhang1, Yihang Qi2, Hiroyuki Inuzuka2
1Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
The Journal of biological chemistry
|August 23, 2024
概括
与O结合的N-乙糖氨基化 (O-GlcNAcylation) 是癌症中关键的蛋白质修饰. 本综述探讨了它在瘤形成中的作用以及作为抗癌药物的治疗点的潜力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 与O结合的N-乙葡萄糖胺化 (O-GlcNAcylation) 是一种对氨酸/氨酸残留物的动态后翻译性修饰.
- 从葡萄糖中衍生出的尿素二酸-N-乙葡萄糖胺是GlcNAc的供体.
- O-GlcNAc转移酶和O-GlcNAc酶调节了O-GlcNAcylation的作用.
- 这种修饰涉及到各种细胞过程,包括癌症.
研究的目的:
- 审查O-GlcNAcylation与瘤相关的生物功能.
- 总结了针对O-GlcNAcylation用于癌症治疗的药物战略的最新进展.
主要方法:
- 在癌症中对O-GlcNAcylation的文献综述.
- 对所涉及的酶途径和蛋白质基质的分析.
- 对新兴药剂及其机制的调查.
主要成果:
- O-GlcNAcylation显著影响瘤发生和癌症进展.
- 特定的蛋白质基质通过O-GlcNAcylation进行调节,影响癌症途径.
- 新兴药物旨在调节O-GlcNAcylation以获得治疗效益.
结论:
- O-GlcNAcylation 是癌症生物学中的一个关键因素.
- 向O-GlcNAcylation为新型抗癌疗法提供了一个有希望的途径.
- 对O-GlcNAcylation调节器的进一步研究是有必要的.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Proteoglycans
3.9K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Oligosaccharide Assembly
2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.8K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
Protein Glycosylation
6.8K
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
6.8K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K

